Why the study?
Does any treatment reduce attack severity or frequency in participants with primary periodic paralyses?
Population
Participants with primary periodic paralyses (hypokalemic and hyperkalemic)
Comparison
Any form of treatment, including… vs Placebo or another treatment
Design
Systematic_review, Included randomised and quasi-randomised trials
Follow-up
8 weeks
Authors
Loading...
Supports dichlorphenamide for attack prevention in periodic paralyses; extends limited evidence base for these rare disorders.
Does any treatment reduce attack severity or frequency in participants with primary periodic paralyses?
Dichlorphenamide is effective in preventing episodic weakness in both hypokalemic and hyperkalemic periodic paralyses, though overall evidence for treatments remains limited.
Sansone et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: